Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3BOEHRINGER INGELHEIM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 9034822

Drug Substance Claim :

Drug Product Claim :

Application Number : 22512

Patent Use Code : U-1759

Delist Requested :

Patent Use Description : METHOD OF REVERSING TH...

Patent Expiration Date : 2031-01-20

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 9034822

Drug Substance Claim :

Drug Product Claim :

Application Number : 22512

Patent Use Code : U-1759

Delist Requested :

Patent Use Description : METHOD OF REVERSING TH...

Patent Expiration Date : 2031-01-20

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

US Patent Number : 9034822

Drug Substance Claim :

Drug Product Claim :

Application Number : 22512

Patent Use Code : U-1759

Delist Requested :

Patent Use Description : METHOD OF REVERSING TH...

Patent Expiration Date : 2031-01-20

blank